MedWellAI MWAI

OTC MWAI
$0.28 -0.04 (-12.50%)
At close: Oct 14, 2026 · 4:00 PM EDT

MedWellAI (MWAI) stock price is $0.28, down 12.50% on the day, as of Oct 14, 2026. It has a market cap of $1.19Mn, and is classified in the Drug Distribution industry (Healthcare sector).

Key Stats
Market Cap1.19 Mn
P/E-0.52
P/S0.83
Div. Yield0.00
Total Debt (Qtr)7.00 Mn
Revenue Growth (1y) (Qtr)119.92
Add ratio to table…

About

MedWellAI, Inc. is a diversified holdings company that develops, acquires, operates, and invests in unique and profitable businesses, with a primary focus on AI driven healthcare and wellness solutions. The company conducts its operations through its subsidiary MedWell USA, which runs a B2B ecommerce platform for distributing pharmaceutical products. In addition to its current healthcare focus, MedWellAI previously engaged in digital asset mining activities and held an…

Read more ↓
Sector: Healthcare Sector rationale The company's dominant business line is MedWell USA, which operates a B2B ecommerce platform for distributing pharmaceutical products, specifically GLP medications, to healthcare providers like wellness clinics and med spas. This activity falls directly under the 'Drug Distribution' industry within the Healthcare sector. While the platform uses AI, the revenue is generated from the sale and distribution of medical products, and previous activities in digital asset mining and consumer sales have been discontinued. Industry: Drug Distribution Drug Distribution Primary MedWellAI operates through its subsidiary MedWell USA, which runs a B2B ecommerce platform for distributing pharmaceutical products, specifically GLP medications. Its primary revenue is generated from product sales to healthcare providers such as wellness clinics and med spas. Classified using BQ-MICS CIK: 0001520118

Statement Class Of Stock Axis Breakdown of Revenue (2025)

History
Peer percentiles

How MedWellAI ranks

Ranked against the 27 companies in Healthcare Payers and Distributors58 metrics · as of Oct 16, 2026

Valuation

12 metrics · Lower multiples rank higher; a negative multiple ranks last
  • P/ENegative earnings −0.72xMedian 25.1x 9th
  • P/FCFNegative free cash flow −4.27xMedian 15.8x 9th
  • P/Operating cash flowNegative operating cash flow −4.62xMedian 13.6x 9th
  • P/S 1.20xMedian 0.36x 13th
  • P/BNegative shareholder equity −0.22xMedian 2.67x Not meaningful —
  • P/Tangible bookNegative tangible equity −0.22xMedian 3.13x Not meaningful —
  • EV/EBITDANegative EBITDA −4.45xMedian 14.3x 15th
  • EV/EBITNegative EBIT −4.40xMedian 19.2x 32nd
  • EV/Revenue 6.00xMedian 0.40x 1st
  • EV/FCFNegative free cash flow −21.3xMedian 17.4x 29th
  • EV/Operating cash flowNegative operating cash flow −23.1xMedian 15.4x 29th
  • PEG (3Y EPS CAGR)Negative earnings −0.02Median 1.37 Not meaningful —
Peer group

Peer Comparison

Companies in the Drug Distribution
View all peers
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 UNH Unitedhealth Group Inc 379.59 Bn26.880.8473.33 Bn
2 CVS CVS HEALTH Corp 121.04 Bn24.750.2961.41 Bn
3 MCK Mckesson Corp 120.97 Bn26.340.299.73 Bn
4 ELV Elevance Health, Inc. 95.30 Bn19.200.4731.04 Bn
5 CI Cigna Group 80.45 Bn12.460.2831.88 Bn
6 COR Cencora, Inc. 66.12 Bn25.190.2011.72 Bn
7 CAH Cardinal Health Inc 60.17 Bn35.100.248.89 Bn
8 MWAI MedWellAI, Inc. 0.00 Bn-0.520.830.01 Bn